Protara Therapeutics (TARA) Exchange Rate Effect (2015 - 2018)
Protara Therapeutics (TARA) recorded quarterly Exchange Rate Effect of -$2000.0 in Q4 2018, up 98.23% quarter-over-quarter from -$113000.0 in Q2 2018, and down 100.53% on a YoY basis from $376000.0 in Q4 2017.
Protara Therapeutics (TARA) Exchange Rate Effect (2015 - 2018) Analysis & Trends
Protara Therapeutics' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$2000.0 for Q4 2018.
- In Q4 2018, Exchange Rate Effect fell 100.53% year-over-year to -$2000.0; the TTM figure through Dec 2018 stood at $22000.0 (down 87.78% YoY), while the FY2018 annual figure was $22000.0, down 87.78% from the prior year.
- Exchange Rate Effect was -$2000.0 for Q4 2018 at Protara Therapeutics, up from -$113000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $376000.0 in Q4 2017 to a low of -$338000.0 in Q2 2017.
- Historically, Exchange Rate Effect has averaged $4384.6 across 4 years, with a median of -$2000.0 in 2018.
- Biggest YoY gain for Exchange Rate Effect was 558.54% in 2017; the steepest drop was 589.8% in 2017.
- A 4-year view of Exchange Rate Effect shows it stood at -$46000.0 in 2015, then slumped by 78.26% to -$82000.0 in 2016, then soared by 558.54% to $376000.0 in 2017, then tumbled by 100.53% to -$2000.0 in 2018.
- The last three Exchange Rate Effect figures came in at -$2000.0 (Q4 2018), -$113000.0 (Q2 2018), and $137000.0 (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 8.68 Mn |
| 10 | Protara Therapeutics | 216.35 Mn | 216.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -2,000.00 |
| Dec 31, 2018 | -2,000.00 |
| Jun 30, 2018 | -113,000.00 |
| Jun 30, 2018 | -113,000.00 |
| Mar 31, 2018 | 137,000.00 |
| Mar 31, 2018 | 137,000.00 |
| Dec 31, 2017 | 376,000.00 |
| Dec 31, 2017 | 376,000.00 |
| Sep 30, 2017 | 83,000.00 |
| Sep 30, 2017 | 83,000.00 |
| Jun 30, 2017 | -338,000.00 |
| Jun 30, 2017 | -338,000.00 |
| Mar 31, 2017 | 59,000.00 |
| Mar 31, 2017 | 59,000.00 |
| Dec 31, 2016 | -82,000.00 |
| Dec 31, 2016 | -82,000.00 |
| Sep 30, 2016 | 27,000.00 |
| Sep 30, 2016 | 27,000.00 |
| Jun 30, 2016 | -49,000.00 |
| Jun 30, 2016 | -49,000.00 |